However, DDX3X has garnered significant attention in recent years and is emerging as a potential therapeutic target for cancer therapy due to its frequent mutations and altered expression in a range of malignancies [48, 49], including prostate cancer [19], pancreatic cancer [50], colorectal cancer [13], head and neck squamous cell carcinoma (HNSCC) [51], oral squamous cell carcinoma [52], breast cancer [53], hepatocellular carcinoma [54], lymphomagenesis [20], and lung cancer [22, 23]
Early firmness improvement
Researchers can use this identifier to locate published literature in PubMed and other scientific databases
Identifying ferroptosis-related genes associated with weight loss outcomes and regulation of adipocyte microenvironment
Genetic studies show that certain variants combined with cannabis use dramatically increase psychosis risk for some people
iso-osmolar contrast agents differ in their ability to trigger ferroptosis, or if dose-dependent thresholds exist, is unclear
